Obesity Prevalence Has Doubled in More Than 70 Countries

This article originally appeared here.
Share this content:
Obesity Prevalence Has Doubled in More Than 70 Countries
Obesity Prevalence Has Doubled in More Than 70 Countries

MONDAY, June 12, 2017 (HealthDay News) -- From 1980 to 2015 the prevalence of obesity doubled in more than 70 countries, according to a study published online June 12 in the New England Journal of Medicine to coincide with the EAT Stockholm Food Forum 2017, held from June 12 to 13.

Researchers from the Global Burden of Disease 2015 Obesity Collaborators assessed trends in the prevalence of overweight and obesity using data from 68.5 million children and adults from 1980 to 2015. They also quantified the burden of disease related to high body mass index (BMI) in 195 countries during the same time period.

A total of 107.7 million children and 603.7 million adults were obese in 2015. The researchers found that the prevalence of obesity doubled in more than 70 countries since 1980, and increased continuously in most other countries. In many countries, the rate of increase in childhood obesity was greater than the rate of increase among adults, although the prevalence of obesity among children was lower than among adults. High BMI accounted for 4.0 million deaths worldwide, with nearly 40 percent in non-obese individuals. Cardiovascular disease accounted for more than two-thirds of the deaths related to high BMI.

"The rapid increase in the prevalence and disease burden of elevated BMI highlights the need for continued focus on surveillance of BMI and identification, implementation, and evaluation of evidence-based interventions to address this problem," the authors write.

Abstract
Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »